Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (311-320 of 356) with videos related to

Pageof 36
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2017
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and ChildrenDavid M Lewinsohn, Michael K Leonard, Philip A LoBue, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2015
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice GuidelineGanesh Raghu, Bram Rochwerg, Yuan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
Journal of Ultrasound|July 9, 2020
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemicAndrea Smargiassi, Gino Soldati, Alberto Borghetti, et al.
Nature Immunology|April 20, 2026
Immunopeptidome profiling in pulmonary fibrosis provides a platform for identifying therapeutic targetsZiyi Bai, Tianxia Lan, Weiqi Hong, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment DecisionsJuergen Behr, Margaret L Salisbury, Simon L F Walsh, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Annals of the American Thoracic Society|December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung DiseaseAlyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
Radiology|January 12, 2021
Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner SocietyTakeshi Johkoh, Kyung Soo Lee, Mizuki Nishino, et al.
Pageof 36

Showing results (311-320 of 356) with videos related to

Sort By:
Pageof 36
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2017
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and ChildrenDavid M Lewinsohn, Michael K Leonard, Philip A LoBue, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2015
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice GuidelineGanesh Raghu, Bram Rochwerg, Yuan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
Journal of Ultrasound|July 9, 2020
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemicAndrea Smargiassi, Gino Soldati, Alberto Borghetti, et al.
Nature Immunology|April 20, 2026
Immunopeptidome profiling in pulmonary fibrosis provides a platform for identifying therapeutic targetsZiyi Bai, Tianxia Lan, Weiqi Hong, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment DecisionsJuergen Behr, Margaret L Salisbury, Simon L F Walsh, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Annals of the American Thoracic Society|December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung DiseaseAlyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
Radiology|January 12, 2021
Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner SocietyTakeshi Johkoh, Kyung Soo Lee, Mizuki Nishino, et al.
Pageof 36